THE RITEDOSE CORPORATION

Lobbying client · South Carolina · filed 2025 to 2026

Pharmaceutical CDMO and Generics Manufacturer.

$420,000 Reported spend

6 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page comes from one LDA client record (68586), filed by the registrant listed below.

Who filed for this client 1

SALT POINT STRATEGIES $420,000 Outside firm · 6 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $270,000 3 filings
2025 $150,000 3 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 5
SENATE 5
Commerce, Dept of (DOC) 2
Executive Office of the President (EOP) 2

Recent filings 6 total

Q3 report

SALT POINT STRATEGIES

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 20, 2026

View → Q2 report

SALT POINT STRATEGIES

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 20, 2026

View → Q1 report

SALT POINT STRATEGIES

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $90,000 income · posted Apr 17, 2026

View → Q4 report

SALT POINT STRATEGIES

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 income · posted Jan 18, 2026

View → Q3 report

SALT POINT STRATEGIES

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025

View → Registration

SALT POINT STRATEGIES

3rd Quarter 2025 (July 1 - Sep 30) · posted Sep 7, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.